Yale Internal Medicine
@YaleIMed
Founded in 1813, Yale Internal Medicine brings together an elite cadre of clinicians, investigators and educators in one of the world's top medical schools.
Researchers are developing a clinical trial for metastatic breast cancer patients that will adapt treatment plans in near real-time. Teams will track biomarkers, which could signal developing treatment resistance & inform therapy choices. @YaleCancer medicine.yale.edu/internal-medic…
In a new study, researchers took a significant step toward understanding IPF by developing an algorithm that interprets disease data and proposes treatments. Learn more about the model & how it can be used for other diseases ⤵️ @YalePCCSM @KaminskiMed medicine.yale.edu/internal-medic…
Researchers have uncovered a critical role a group of molecules plays in parasite development. They're developing a first-of-its-kind assay that has potential to enhance drug discovery for a wide variety of diseases, including cancer & neurodegeneration. medicine.yale.edu/internal-medic…
Researchers uncovered how autoantibodies influence treatment response using cutting-edge technology developed at Yale. Learn more about why these treatments only work for some patients. @YaleCancer @YaleMed medicine.yale.edu/internal-medic…

Melissa Shaw is a research associate with the Clinical and Translation Research Accelerator in @YaleNephrology. Shaw develops, implements, and oversees various research studies. Learn more about Shaw and her work. medicine.yale.edu/internal-medic…

A new pilot program, the Yale Medicine Heart and Vascular Psychology and Wellbeing Clinic, will expand access and provide integrated psychological care for people with heart conditions. Read more from @KimGSmolderen of @YaleCardiology. medicine.yale.edu/internal-medic…

Stories of tennis courts and hospital wards, of Uganda and Georgia, of new mothers, dying friends, and failing systems were among those shared during the 9th Annual Stories of Yale Internal Medicine MGR. Below are brief glimpses into the stories shared🔗 medicine.yale.edu/internal-medic…

In a Phase II clinical trial, researchers found a new drug, maridebart cafraglutide (MariTide), was effective at reducing weight in patients with obesity with just once-monthly doses. Learn more about the study from Dr. @AniaJastreboff. medicine.yale.edu/internal-medic…

The 2025 Iva Dostanic, MD, PhD, Physician-Scientist Trainee Award was presented to two recipients: Benjamin Y. Lu, MD, PhD, and Abinet M. Aklilu, MD, MPH, in late June. Learn more about Lu and @Nephronette, their research, and the history of the award: medicine.yale.edu/internal-medic…

“I try to be calm during the storm,” says @ElliottMillerMD about practicing in Yale’s Cardiac Intensive Care Unit (CICU). In a Q&A, Miller discusses his teaching approach, what makes the CICU unique & why he believes there is no better job in medicine⬇️ medicine.yale.edu/internal-medic…

📸 Dr. William Chang presented a very exciting @YaleIMed MGR this morning on his cutting edge research and perspectives on the future of tissue engineering in nephrology!
Dr. Snigdha Jain & Dr. Bubu Banini were recognized by @theNAMedicine as '25 Scholars in Diagnostic Excellence. Jain's project is focused on prolonged sedation & ventilator use in the ICU & Banini's focus is early detection of liver diseases using AI. 📰medicine.yale.edu/internal-medic…

PGY-1 Sowmya Ravi, MD, MPH, was inspired by her pediatrician mother to pursue a career in medicine. Ravi is passionate about bridging gaps in health care disparities. Learn more about her ⬇️ medicine.yale.edu/internal-medic…

Following a heart transplant, patients must undergo surgical biopsies to monitor for signs of organ rejection. A new patient study shows the promise of a biomarker that could allow doctors to replace these invasive biopsies with a simple blood test. medicine.yale.edu/internal-medic…
Patients who are treated with checkpoint inhibitors can develop irreversible diabetes. Dr. Ana Luisa Perdigoto discusses how it can induce diabetes, patients who may be more susceptible & research seeking to prevent & treat this life-altering condition. medicine.yale.edu/internal-medic…
Dr. Diana Athonvarangkul studies the role of parathyroid hormone-related protein & bone physiology during lactation. She seeks to understand how lactation-associated bone loss & recovery are regulated & can be targets for osteoporosis treatment. medicine.yale.edu/internal-medic…
A new study finds that an AI-enabled tool can interpret echocardiograms with a high degree of accuracy. The tool could perform diagnostic tasks based on multi-view echocardiography & accurately detect conditions in a few minutes time. Learn more ⬇️ medicine.yale.edu/internal-medic…
The Liver Center seeks letters of intent for pilot projects ($40,000 direct costs each) from both Liver Center and non-Liver Center investigators. Letters of intent are due Friday, July 18, 2025. Learn more about the criteria below. @YaleDigestive medicine.yale.edu/news-article/a…
Dr. Mei Xue Dong has been named a recipient of the 2025 Edwin C. Cadman Teacher of the Year Award. Dong is praised for her clarity, warmth & unwavering commitment to education & her ability to break down complex rheumatologic topics. Learn more. medicine.yale.edu/internal-medic…
The Primary Care Residency Program and Traditional Residency Program held ceremonies to celebrate the achievements of graduating residents. Read more about the residents and faculty members who received awards. medicine.yale.edu/internal-medic…